We're committed to providing you with the very best cancer care, and your safety continues to be a top priority. With this in mind, we’ve put in place many new procedures, including a limited visitor policy and are not allowing patients to have people with them during appointments. This is just one more way of ensuring your safety and that of our staff. Read more
Assistant Professor, National Defense Medical College, Saitama, Japan
Eguchi T, Kameda K, Lu SH, Bott MJ, Tan KS, Montecalvo J, Chang JC, Rekhtman N, Jones DR, Travis WD, Adusumilli PS. Lobectomy is associated with better outcomes than sublobar resection in spread through air spaces (STAS)-positive T1 lung Adenocarcinoma: a propensity score-matched analysis. J Thorac Oncol. 2019;14(1):87-98.
Kameda K, Eguchi T, Lu S, Qu Y, TanKS, Kadota K, Adusumilli PS, Travis WD. Implications of the eighth edition of the TNM proposal: invasive vs. total tumor size for the T descriptor in pathologic stage I-IIA lung adenocarcinoma. J Thorac Oncol. 2018;13(12):1919-1929.
Takahashi Y, Eguchi T, Kameda K, Lu S, Vaghjiani RG, Tan KS, Travis WD, Jones DR, Adusumilli PS. Histologic subtyping in pathologic stage I-IIA lung adenocarcinoma provides risk-based stratification for surveillance. Oncotarget. 2018;9(87):35742-35751.